Associate Director, Worldwide Medical Oncology, Medical Communications at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, OncologyIndustries

Requirements

Strong business acumen with ability to interface with matrix partners to make trade-off decisions, managing Medical Communications budget and allocation of funds/resources to highest business priorities
Scientific/research expertise to support collaborations with internal and external disease-area experts for quality data analysis, interpretation, communication planning, and data disclosure/dissemination
Expertise in communication landscape, HCP preferences, publication and scientific content planning, data disclosure/dissemination
Knowledge of Good Publication Practices, industry standards, and ethical practices for publications and scientific content

Responsibilities

Establish a clear, viable, and compelling strategy for Medical Communications aligned with overall Medical vision, strategy, and objectives; ensure delivery of timely and high-quality medical publications, scientific content, medical education, medical information, and congress presentations
Understand communication needs across markets; own pull-through and execution of the Scientific Narrative, development and execution of functionally integrated publication plan, content plan, and application to the Scientific Communication Platform (SCP)
Lead development of medical communications; ensure timely journal submissions, publications, congress presentations, and delivery of internal and external scientific content
Serve as subject matter expert to BMS internal audiences on communication landscape, HCP preferences, publication/scientific content planning, data disclosure/dissemination; represent BMS scientific communications to external investigators, key authors, and journal editors
Lead internal process improvements to ensure BMS remains an ethical and credible leader in publications and scientific content; lead transformation efforts to align with Good Publication Practices and industry standards; ensure all BMS employees follow GPP with integrity, quality, and transparency
Provide oversight to the team for development and execution of functionally integrated and aligned medical communications plans; adjust plans based on clinical trial results/milestones and changes in the healthcare landscape
Demonstrate scientific/research expertise to establish strong collaborations with internal/external disease-area experts for data analysis, interpretation, communication planning, and dissemination
Ensure collection of insights to deliver high-quality medical communication enabling impactful dialogue and interactions with customers
Identify and drive opportunities to enhance processes, tools, operating procedures, and outsourcing strategies

Skills

Medical Communications

Publication Planning

Scientific Strategy

Medical Affairs

Health Economics

Congress Presentations

Medical Education

Scientific Content Development

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free